Equity Alert: Sun Pharma gains 3%; resistance seen at 1,520 rupees
MUMBAI--3:15PM--Sun Pharmaceutical Industries gained 3% at 1,468
rupees on
defensive buying in a weak market coupled with short covering, dealers
said.
"The stock looks attractive, compared with other stocks like
Ranbaxy. One
can buy it at the current level,"
Analysts are positive on the stock because its valuations look
attractive, but do not expect any significant surge as there are no
triggers.
So far today, over 0.1 mln shares of Sun Pharmaceutical Industries
have
been traded on NSE.
September contract of the stock was trading nearly at par to spot
price,
with a 4% fall in open interest.
The Sun Pharmaceutical Industries stock is seen facing resistance
at
1,520 rupees and then at 1,535 rupees, said Kiran Suvarna, technical
analyst,
Finquest Securities.
------------------------------------------------------------------------------
--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google Groups
"Kences1" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to [EMAIL PROTECTED]
For more options, visit this group at
http://groups.google.com/group/kences1?hl=en
-~----------~----~----~----~------~----~------~--~---
